An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies

TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!

Our own Kelly Close moderates a panel at SXSW Interactive.

Approaching the conversation, words and phrases to use, and more!

“We have to create solutions in diabetes that are as addictive as the iPhone.”

How will this expansion help tackle urban diabetes worldwide?

Details for Dexcom July 21 Advisory Panel meeting posted. How to submit a written statement to the FDA or attend in person.

“We need to support people at risk and prevent diabetes before it even happens.”

A call to action to make this invisible disease visible.

Understanding the UnitedHealthcare/Medtronic partnership in the context of the Affordable Care Act.

Given that this plantation and all others like it were dedicated to sugar, the connection to diabetes is especially stark.

A standing ovation for Dr. Margaret Powers at ADA last month r Dr. Margaret Powers at ADA last month.

Dell Medical School’s Dr. Sue Cox leads SXSW 2017 panel on how redesigning medical education may improve diabetes care delivery

The diaTribe Foundation convenes key diabetes experts to discuss glycemic outcomes beyond A1C on July 21, 2017, in Bethesda, MD

The diaTribe Foundation and TCOYD host discussion at ADA focusing on access, outcomes beyond A1c, and future expectations

How one court ruling may reverse Medicare’s policy denying coverage of most CGMs

Recommendations from the American College of Physicians focus on relaxing A1c goals without considering up-to-date CGM and therapy options

ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!

JDRF Chief Mission Officer Dr. Aaron Kowalski has been named the organization’s next President and CEO. See our exclusive interview with Dr. Kowalski!

Over 160 children and teens living with type 1 diabetes were selected to travel to Washington D.C. for three days, meeting with politicians and lawmakers to advocate for...